The Elimination Rate after Clozapine Overdose in Chinese Schizophrenia Patients: A Population Pharmacokinetics Model Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
The Elimination Rate after Clozapine Overdose in Chinese Schizophrenia Patients: A Population Pharmacokinetics Model Study ; volume:48 ; number:04/05 ; year:2015 ; pages:e2-e2
Pharmacopsychiatry ; 48, Heft 04/05 (2015), e2-e2
- Contributor
-
Li, A.-N.
Dong, F.
He, J.-L.
Shang, D.-W.
Guo, W.
Li, W.-B.
Lu, W.
Wang, C.-Y.
- DOI
-
10.1055/s-0035-1555803
- URN
-
urn:nbn:de:101:1-2018112106433639224819
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, A.-N.
- Dong, F.
- He, J.-L.
- Shang, D.-W.
- Guo, W.
- Li, W.-B.
- Lu, W.
- Wang, C.-Y.
Other Objects (12)
An international research agenda for clozapine-resistant schizophrenia
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Pharmacokinetics of anticoagulant edoxaban in overdose in a Japanese patient transported to hospital
Clozapine-induced agranulocytosis
Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
An international research agenda for clozapine-resistant schizophrenia
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Pharmacokinetics of anticoagulant edoxaban in overdose in a Japanese patient transported to hospital
Clozapine-induced agranulocytosis
Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
An international research agenda for clozapine-resistant schizophrenia
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Pharmacokinetics of anticoagulant edoxaban in overdose in a Japanese patient transported to hospital
Clozapine-induced agranulocytosis